iRadimed Corp. (IRMD)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$83.45-3.63%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · IRMD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 28.6% |
| Our one-year growth estimate | diamond | 12.6% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 16.0 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
IRMD — earnings miss
Dated 2026-08-18
of the Original Report is not being amended or changed. On July 31, 2026 , IRADIMED CORPORATION issued a press release (the “Press Release”) announcing its financial results for the quarter ended June 30, 2026. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or othe…
Why it matters: Better cash flow means the company is running well and is financially strong. This helps with investments and dividends.
Supportive ifCash flow from operations reported above $6 million in Q3.
Worry ifCash flow from operations reported below $6 million in Q3.
Why it matters: This revenue range is key to confirming the expected ramp from the new 3870 pump. Meeting or exceeding this range would show strong demand and growth.
Supportive ifQ3 revenue reported at $24.5 million or higher.
Worry ifQ3 revenue reported below $23.0 million.
Why it matters: This EPS range is important to gauge if the company can maintain its earnings growth trajectory. Achieving this range would support ongoing financial health.
Supportive ifGAAP EPS reported at $0.54 or higher.
Worry ifGAAP EPS reported below $0.49.
Why it matters: If healthcare sector growth speeds up, it could benefit iRadimed's performance. Investors will watch for signs.
Supportive ifHealthcare sector revenue growth speeds up to over 10% each year.
Worry ifHealthcare sector revenue growth remains below 9% year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$100 on $10,000 · ±1.0% | How much price usually moves either way. |
| Bad day | $307 loss on $10,000 · 3.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,062 loss on $10,000 · 20.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Improving gross margins signal better efficiency and profitability from the new 3870 pump. This is key for long-term growth.
Supportive ifGross margin reported above 75% for Q3.
Worry ifGross margin reported below 74% for Q3.
Why it matters: This payment shows the company cares about giving value to shareholders. It shows they are stable.
Watch forDividend payment of $0.20 per share is made on August 28, 2026.
Also watch forThe dividend payment is late or not happening.
Why it matters: Strong early orders for the 3870 pump can drive revenue growth and validate the product's market fit.
Supportive ifEarly orders for the 3870 pump are larger than past orders.
Worry ifEarly orders for the 3870 pump are smaller than expected.
Why it matters: Strong bookings for the new pump indicate market acceptance and future revenue growth. This is crucial for the company's transition to the new product line.
Supportive ifBookings for the 3870 pump exceed previous quarter's bookings.
Worry ifBookings for the 3870 pump decline compared to the previous quarter.
Why it matters: Stable cash flow shows the company can pay its bills and grow. A drop may mean money problems.
Watch forCash flow from operations is over $5 million.
Also watch forCash flow from operations is under $5 million.